Jefferies Financial Group’s Charles River Laboratories CRL Stock Holding History

Jefferies Financial Group’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.14M	Buy	+18,270	New	+$3.25M	0.03%	432
2025 Q4	–	Sell	-5,000	Closed	-$782K	–	1899
2025 Q3	$782K	Sell	5,000 -3,872	-44%	-$615K	﹤0.01%	948
2025 Q2	$1.35M	Sell	8,872 -4,742	-35%	-$632K	0.01%	635
2025 Q1	$2.05M	Sell	13,614 -4,188	-24%	-$702K	0.02%	576
2024 Q4	$3.29M	Buy	17,802 +12,353	+227%	+$2.38M	0.02%	500
2024 Q3	$1.07M	Buy	+5,449	New	+$1.13M	0.01%	768
2024 Q2	–	Sell	-8,720	Closed	-$2.36M	–	1489
2024 Q1	$2.36M	Buy	+8,720	New	+$2.08M	0.02%	536
2023 Q4	–	Sell	-1,199	Closed	-$235K	–	1747
2023 Q3	$235K	Buy	+1,199	New	+$246K	﹤0.01%	1291

Other funds holding CRL

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Jefferies Financial Group's CRL Position: Q2 2026 in Review

Jefferies Financial Group opened a new position in Charles River Laboratories (CRL) in Q2 2026: 18,270 shares worth $4.14M. The stake represents 0.03% of the portfolio and ranks #432 among its holdings. This is a return to the name: Jefferies Financial Group previously reported a position in CRL as recently as Q3 2025.

Jefferies Financial Group first reported a position in CRL in Q3 2023 and has held it in 8 quarters since. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

Jefferies Financial Group held 18,270 shares of Charles River Laboratories worth $4.14M as of Q2 2026.
Charles River Laboratories was a new Jefferies Financial Group position in Q2 2026.
Charles River Laboratories made up 0.03% of Jefferies Financial Group's portfolio in Q2 2026, its #432 holding.
Jefferies Financial Group first reported a position in Charles River Laboratories in Q3 2023 and has held it in 8 quarters since.
570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.